Mechanism:

Oral androgen treatment, balances a deficiency of androgen formation which begins to fall gradually with an increasing age.

Suitable for all conditions caused by a deficient endogenous androgen formation.

In the recommended therapeutic dose, it will not impair spermatogenesis

Well tolerated by the liver.

Indications:

Declining physical activity and mental alertness in middle and old aged men attributeed to androgen deficiency.

Potency disturbances due to androgen deficiency.

Hypogonadism.

Male infertility.

Main Use:

Potency disturbances. Proviron overcomes potency disturbances due to androgen deficiency.It may also be of use as supplementary therapy in cases of diminished potency where androgen deficiency is not the primary cause.

Hypogonadism. Growth, development and function of androgen dependant target organs are stimulated by Proviron.It promotes development of secondary male sex characteristics in cases of prepuberal hypogonadism.Full clinical and laboratory investigations are necessary in all cases of young patients prior to commencement of treatment.Proviron tablets may also be used as a substitute therapy in cases where a loss of gonadal function has occured post-puberally.

Infertility. Oligozoospermia and deficient Leydig cell secretion may be the cause of infertility.With Proviron treatment, sperm count can be increased, the quality improved and further more, a higher fructose concentrations up to normal values can be achieved thus increasing the chances of procreation.

Notes:

If not otherwise directed by a physician, the following dosage is recommended:in declining physical activity and potency disturbances: Commencement treatment: One 25mg tablet 3 times a day. Continuation of treatment:One 25mg tablet 1 - 2 times a day.

According to type and severity of complaints, a course of Proviron lasting 4 - 6 weeks or a prolonged uninterupted treatment of several months is recommended.If required, the course of treatment may be repeated several times.

Hypogonadism requires continous therapy: For development of secondary male characteristics one Proviron 25mg tablet 3 - 4 times daily for several months. As maintenance dose one Proviron tablet of 25mg 2 - 3 times daily will be sufficient.

In oligospermia, one Proviron tablet of 25mg 2 - 3 times a day for the cycle of spermatogenesis ie. 90 days. In cases of simultaneously impaired gonadotrophic excretion, a combined therapy with gonadotrophic hormone exhibiting FSH activity is recommended for the commencement of treatment (eg.2000 IU serum gonadotrophin I/M twice weekly up to a total of 12000 IU).If necessary Proviron treatment is to be repeated after an interval of several days